Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Praduman Jain, CEO and Founder of Vibrent Health, accepted into Forbes Technology Council

Vibrent Health

Praduman Jain, CEO and founder of Vibrent Health, a digital health technology company powering the future of precision health research, has been accepted into Forbes Technology Council, an invitation-only community for world-class CIOs, CTOs, and technology executives. Jain was vetted and selected by a review committee based on the depth and diversity of his experience. Criteria for acceptance include a track record of successfully impacting business growth metrics, as well as personal and professional achievements and honors. “We are honored to welcome Praduman into the community,” said Scott Gerber, founder of Forbes Councils, the collective that includes Forbes Technology Council. “Our mission with Forbes Councils is to bring together proven leaders from every industry, creating a curated, social capital-driven network that helps every member grow professionally and make an even greater impact on the business world.” As an accepted member of the Council, Praduman has access to a variety of exclusive opportunities designed to help him reach peak professional influence. He will connect and collaborate with other respected local leaders in a private forum. Praduman will also be invited to work with a professional editorial team to share his expert insights in original business articles on Forbes.com and to contribute to published Q&A panels alongside other experts. Finally, Praduman will benefit from exclusive access to vetted business service partners, membership-branded marketing collateral, and the high-touch support of the Forbes Councils member concierge team. "As we work to reimagine global health research and power the future of precision medicine, this acceptance from Forbes will allow us to share our insights and knowledge in new ways,” said Jain. “Our mission is to accelerate health research through digital tools and with the support of the Forbes platform we can help our industry move forward. I am excited about being included in this exclusive group of technology thought leaders and look forward to sharing my experiences and learning from other members.” ABOUT FORBES COUNCILS Forbes Councils is a collective of invitation-only communities created in partnership with Forbes and the expert community builders who founded the Young Entrepreneur Council (YEC). In Forbes Councils, exceptional business owners and leaders come together with the people and resources that can help them thrive. For more information about Forbes Technology Council, visit forbestechcouncil.com. To learn more about Forbes Councils, visit forbescouncils.com. About Vibrent Health Vibrent Health develops digital health technology and research tools for health organizations, researchers, and research participants. Powering the next generation of precision medicine, Vibrent’s scalable technology platform for individual and population health provides actionable insights to help accelerate medical discoveries. Vibrent Health is proud to serve, since 2016, as the Participant Technology Systems Center for the National Institutes of Health’s All of Us Research Program, which aims to collect health data from one million or more people to support a wide variety of research studies. This work is supported under NIH funding award U24OD02316. To learn more, visit vibrenthealth.com. Contact Details Vibrent Health Pearson Brown +1 310-994-7057 pbrown@vibrenthealth.com Company Website https://vibrenthealth.com

June 15, 2021 09:22 AM Eastern Daylight Time

Image

Velocity Global commits $1M to First Descents to expand adventure programs for young adults coping with multiple sclerosis

Velocity Global

First Descents (FD) has announced a transformative $1 million contribution from Velocity Global to support the expansion of adventure programs for young adults living with multiple sclerosis (MS). Funds will support program development and help reach more than 1,000 MS participants over the next 5 years. “First Descents serves people first to fill a gap in psychosocial supportive care for young adults living with MS. Velocity Global is honored to support the expansion of these programs through this donation and volunteer efforts from our global team,” said Ben Wright, founder and CEO of Velocity Global. “I have witnessed the healing impact of First Descents programs firsthand, and am proud our company is in a position to advance this important work.” Velocity Global and First Descents share a special partnership that transcends financial support. The two Colorado-based companies began as office neighbors at INDUSTRY Denver in 2014. Over the years, Velocity Global employees have volunteered on First Descents programs and fundraised while competing in the Ragnar Snowmass Relay and the TransRockies Run. In 2018, Velocity Global contributed $150,000 to pilot MS programming which began with a whitewater kayaking experience in Tarkio, Montana. “Velocity Global’s support will help us to serve more than 1,000 young adults living with MS in the coming years while investing in vital partnerships with patient advocacy groups and neurology clinics nationwide,” observes Ryan O’Donoghue, CEO, First Descents. “We want MS patients to learn about First Descents closer to the time of diagnosis and know that we are here for them. Velocity Global’s leadership support will make this vision a reality.” The National MS Society indicates there are approximately 1 million people living with multiple sclerosis in the United States with approximately 10,000 new cases diagnosed each year. Typically, MS is diagnosed between the ages of 20 and 50, with a median age of diagnosis at 34. Young adults living with MS can experience significant physical, neurological and psychosocial changes that often disrupt important developmental milestones. In addition to the complexities of clinical treatments and lifestyle implications, the relapsing and progressive nature of MS can be daunting, and can result in significant psychosocial distress. According to the National MS Society, clinical depression ranks among the most common comorbidities associated with MS. These realities have been further exacerbated by the COVID-19 pandemic where prolonged social isolation and apprehension for the future have taken a significant toll. First Descents is working with several renowned patient advocacy groups, including the Multiple Sclerosis Association of America (MSAA) to reach more people coping with MS. “There is an important need to support young adult MS patients with age appropriate programming that can improve their outlook and quality of life,” observes Gina Ross Murdoch, CEO, Multiple Sclerosis Association of America. “Staying fit and active - especially with peers living with MS - can greatly benefit patients’ mental and physical health. We are excited to work with First Descents and Velocity Global on the launch of these programs.” First Descents’ all-inclusive programs are free of charge to participants. All programs ensure ADA lodging compliance, a tailored Wahls protocol nutrition program, and fully-accessible outdoor activities. Further, programs are designed with careful consideration to mitigate heat sensitivity, balance issues, and fatigue. Ultimately, First Descents creates an environment where young adults with MS can reclaim their physical agency, explore new activities, and nurture lifelong supportive peer relationships. ### ABOUT VELOCITY GLOBAL Velocity Global accelerates the future of work beyond borders. Its platform enables businesses to employ remote teams and expand internationally through global expertise, best-in-breed technology, and scale. More than 700 brands rely on its Employer of Record model and infrastructure, also called an International PEO (Professional Employer Organization), in 185 countries and all 50 United States to compliantly employ thousands of supported employees, access global talent, and grow revenue. Named a “Leader” in Global Employer of Record services by prominent analyst firm NelsonHall, Velocity Global is a strategic partner to its clients through additional comprehensive services including Immigration, Independent Contractor Compliance to assess a workforce, and Agent of Record (AoR) to streamline payments to contractors globally. Founded in 2014, the company is headquartered in Denver, Colorado, with regional headquarters in Amsterdam, Bogotá, and Singapore, with local employees in 16 countries. ABOUT FIRST DESCENTS First Descents (FD) is a leader in adventure-based healing. Through outdoor adventure, community building, and lifestyle development, FD improves long-term survivorship and quality of life for young adults impacted by cancer, multiple sclerosis, and other serious health conditions. Headquartered in Denver, First Descents has served more than 10,000 participants over the last 20 years. Beginning in 2020, First Descents launched programs for healthcare workers on the frontlines of COVID-19. All services are fully-adaptive and free of charge. A Guidestar Platinum-ranked nonprofit, First Descents has been recognized on CNN Heroes and Outside Magazine's Best Places to Work. RESOURCES: First Descents MS Program Page Contact Details Velocity Global John Hall +1 720-650-4348 johnhall@velocityglobal.com First Descents Ray Shedd +12034999633 ray.shedd@firstdescents.org Company Website https://velocityglobal.com/

June 15, 2021 07:02 AM Mountain Daylight Time

Video

Sophisticated Compensation Enhancements Added to SullivanCotter’s Innovative Provider Performance Management Technology™ Platform

SullivanCotter

SullivanCotter, the nation’s leading independent consulting firm in the assessment and development of total rewards programs, workforce solutions, and technology and data products for the health care industry and not-for-profit sector, announces the addition of highly-anticipated new compensation automation enhancements to its growing Provider Performance Management Technology ™ (PPMT) platform. PPMT™ is an industry-first, cloud-based product that engages clinicians through transparent performance-based compensation administration, contract management, and analytical and reporting capabilities. With the new Clinician Pay feature, PPMT™ now enables users to streamline the compensation management process by automating clinical draw calculations and payments based on current performance and organization-defined criteria. It offers flexible and sophisticated rules for the draw calculations that are easily maintained by key administrative stakeholders and can be managed throughout the year. “Determining clinician draw for the upcoming year is a significant and burdensome time investment for compensation program administrators. Most often, these calculations are done manually via spreadsheets – which can greatly increase the risk of error. Using PPMT™, organizations can now automate the production of accurate and reliable draw and other pay calculations within one system”, said Shelly Slowiak, Director, Product Support, PPMT™, SullivanCotter. New split role compensation automation eliminates the need to manually determine clinical and non-clinical pay components by providing visibility into performance and compensation for different roles while also allowing administrators to view aggregate compensation for each individual clinician. “In order to provide the best care for patients, a growing number of physicians are specializing in multiple service areas with varying compensation arrangements. This often requires greater attention and additional analysis from an already overextended compensation team. PPMT™ can ease the administrative burden by effectively automating and providing consistent compensation calculations for each service area”, said David Schwietz, Chief Information Officer, SullivanCotter. Designed to address a spectrum of physician, leadership and other key stakeholder needs, PPMT™ combines years of health care compensation insight and expertise with an intuitive and automated technology platform to help drive provider performance and support the transition from volume- to value-based care. For more information on these enhancements or our entire suite of Provider Performance Management Technology™, visit www.sullivancotter.com/PPMT or contact us at 888.739.7039. About SullivanCotter SullivanCotter partners with health care and other not-for-profit organizations to understand what drives performance and improve outcomes through the development and implementation of integrated workforce strategies. Using our time-tested methodologies and industry-leading research and information, we provide data-driven insights, expertise, data and technology products to help organizations align business strategy and performance objectives – enabling our clients to deliver on their mission, vision and values. Contact Details Becky Lorentz +1 314-414-3719 beckylorentz@sullivancotter.com Company Website https://sullivancotter.com

June 15, 2021 07:00 AM Central Daylight Time

Secta Finance innovates the £10b private school fees model, making affordable finance options for parents

Stockwood Strategy

Fintech business Secta Finance has launched today to transform how private school fees are paid. Families are spending circa £10b every year to pay school fees for over 620,000 children and over the years there has been no innovation on the termly bill payments. Secta Finance has set out to change this and become an enabler for many more families considering private schooling but feel it is currently unaffordable. In collaboration with a number of financial institutions, Secta Finance has created a range of flexible and highly competitive finance plans that enable parents (and would-be parents) to spread the cost of private school fees over many years in a simple affordable way. The Secta Flexiplan enables parents to use the equity in their home to secure a facility that allows parents to draw funds flexibly within the first 5 years. Parents only pay interest on the amount they actually drawdown. If they don’t need to draw funds there is no cost. Parents can decide how much they draw; their monthly repayment amounts (subject to a minimum) and the term they repay over (up to 30 years). Also, there are no early repayment fees if they choose to repay in full. Below is an example* of how a Secta Flexiplan could be used to finance 5 years of private education. This example is based on one child, annual school fees of £15,000 per year and with the Secta Flexiplan being repaid over a period of 10 or 20 years. However, the amount borrowed, the term over which it is repaid and the monthly repayments can be adjusted to suit individual circumstances and preferences. Secta Finance has made it quick and simple for parents to get indicative quotes from their online platform. Thereafter they can engage with a qualified advisor to discuss their options and tailor a plan to suit their needs. Joe Hill, founder and CEO of Secta Finance commented: “How parents pay for private school fees is no longer fit for purpose. They are still paying large lump sums, sometimes, with expensive and inflexible means using credit cards or unsecured loans, that simply is not sustainable. Secta has set out to challenge this approach with a fresh lens and a clear pathway for parents to handle this significant expense. We want to create manageable and affordable finance solutions for school fees, much like the financial products people consider when buying a house or a car.” Contrary to popular belief, private education is not confined to the wealthy, but many middle class parents place a very high value on it and want to provide the benefits of a private education for their children. However, the costs can be prohibitive, especially for families with more than one child. Annual average school fees are in excess of £15,000 for day schools and in excess of £30,000 for boarding schools. Factoring in additional costs, a private education can cost an average of £325,600 per child for day school and £469,700 for boarders starting their schooling in 2019. Unsurprisingly, many parents find this a struggle. Research completed by Killik and Co suggests that private day school fees have increased by 403% since 1990. “Many parents make significant sacrifices to give their children a private school education. But it doesn’t have to be that way. It makes sense to have a solution whereby parents can spread the cost over a longer period of time if they wish (up to 30 years), to reduce the strain on their finances, but still be able to give their children a private education,” added Joe Hill. There are more than 2,500 independent schools in the UK catering for approximately 620,000 pupils. This represents about 7% of all UK school children and 18% of pupils over aged 16 years and older. The estimated school fee market value is approximately £11 billion. Secta Finance is working closely with schools who are keen to offer meaningful finance options for their parents. The company is also collaborating with independent financial advisors who are seeking flexible, efficient options for their clients. Parents are also directly engaging with the online platform to find out more about the options available to them. Looking ahead Joe Hill added: “We are creating opportunities for parents, for schools and for children. By offering finance solutions which are affordable, simple to understand, we will create a sustainable path for better outcomes. Our strategic aim is to expand the opportunity of private education to many more families and enable a sustainable relationship for parents and schools through the products that we offer”. ENDS *This is an indicative quote and does not constitute an offer or advice. Interest rate and solution terms will depend on your circumstances and the amount of the loan. Before you make a loan application, we will carry out a full review to establish your needs and preferences and if you meet the criteria, we will give advice and make a recommendation to you. All loans are subject to status. Please note that our product calculators show an indicative rate only and may not be suitable for you. Your home may be repossessed if you do not keep up with your repayments. About Secta Finance Our mission is to relieve the pressure of private school fees by providing innovative, affordable finance solutions to parents. In doing so, we bring the outstanding benefits of private education within the reach of many more families, everywhere. Secta Finance Limited is authorised and regulated by the Financial Conduct Authority. Contact Details Secta Finance Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.sectafinance.co.uk/

June 15, 2021 04:30 AM Eastern Daylight Time

Image

The Impact of Hearing Loss and What You Can Do About It

YourUpdateTV

Hearing loss has been shown to affect nearly every dimension of human life, including physical, emotional and mental health. Recently, World Champion and Olympic Kayaker, Eric Jackson, participated in a nationwide satellite media tour to discuss his own battle with hearing loss and the importance of getting your hearing tested. A video accompanying this announcement is available at: https://youtu.be/0Ewdu9hNHF8 Hearing loss is the most common neurologic disorder in the world, affecting around 460 million people. According to the National Institutes of Health, about 37.5 million adults report some trouble hearing. Experts note that hearing loss is an undertreated condition, with an estimated 28.8 million U.S. adults with mild to severe hearing loss could serve to benefit from hearing aids. Untreated hearing loss brings higher risk of dementia, depression, memory loss, injury, and cognitive decline. There are several reasons for delay in addressing hearing loss, including recognizing and accepting that one may have hearing loss, having access to Hearing Care Professionals, and misperceptions associated with hearing aids. For Eric Jackson, hearing loss has been a lifelong battle. In 1966 at the age of two, Eric contracted Scarlet fever which caused him to completely lose his hearing in both ears. Eric is now 57 and his hearing has been partially restored over time; however, he still lives with severe hearing loss today and relies on hearing aids like ReSound ONE as necessary tools to help him communicate. All of ReSound’s hearing aids are designed with the person in mind, and is made to be discreet, comfortable, durable and functional. Hearing quality is the foundation for ReSound hearing aids, providing unmatched hearing quality, emulating the way humans hear sound. For more information, visit resound.com/online-hearing-test About Eric Jackson: Eric Jackson is a four-time world champion and an Olympian who has dominated the whitewater kayaking scene for the past three decades. Eric has received numerous accolades for kayaking, including two Everest Awards and the World Paddle Lifetime Achievement Award. He is also an entrepreneur, motivational speaker and hosts his own popular videos on YouTube. In 1966 at the age of two, Eric contracted scarlet fever which caused him to completely lose his hearing in both ears. Eric is now 54 and his hearing has been partially restored over time; however, he still lives with severe hearing loss today and relies on hearing aids and lipreading as tools to help him communicate. Eric has never let hearing loss stop him from enjoying life and pursuing his ambitions. Today, Eric spends his free time helping others achieve their goals, coaching the winners of almost every gold medal winner in freestyle kayaking over the past 15 years, including his two children. Eric’s son, 27-year-old Dane, a world champion kayaker himself, also lives with severe hearing loss which he has had since birth About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

June 11, 2021 03:00 PM Eastern Daylight Time

Video

Centre for Neuro Skills Sets June 24 as Grand Opening for New Austin, Texas Clinic

Centre for Neuro Skills

The Texas Brain Injury Alliance reports that 144,000 Texans sustain a traumatic brain injury each year - one every 4 minutes. The Texas Department of State Health Services reports that approximately 72,500 Texas residents have strokes each year that require hospitalization. Now, more help is on the way. Centre for Neuro Skills (CNS), a premier provider of treatment for traumatic and acquired brain injury, announced the grand opening date of its new clinic in Austin, Texas. The clinic will celebrate with an invitation-only open house on Thursday, June 24. Former CNS patients Justin Glick and Megan Guerra are guest speakers who will share their rehabilitation stories. The 17,000-square-foot facility is located at 14425 Falconhead Blvd., Building F, Suite 200, Austin. A virtual tour of the new facilities is available. To access the tour, please click here. The Austin clinic is CNS’ fourth location in Texas, joining Dallas, Fort Worth and Houston. CNS also treats patients at three facilities in California. All CNS clinics offer a continuum of care approach to therapeutic rehabilitation and disease management services for those recovering from acquired and traumatic brain injuries. “No two brain injuries are the same,” said CNS’ Chief Medical Officer, Dr. Matthew Ashley. “What sets CNS apart is our whole team focus on patients and their caregivers. This new clinic will allow us to provide localized quality care to brain injury patients in Austin and Central Texas, which will ensure better recovery. Our goal is to maximize independence and improve quality of life.” Patient Success Story – Justin Glick Former CNS patient Justin Glick and his wife Caroline relocated to Austin from Los Angeles in 2020. They have since had their first baby, Sienna. After sustaining a traumatic brain injury at work, Justin sought treatment at the CNS Los Angeles clinic. He made a remarkable turnaround in just 47 days. Justin had spent his career in a highly specialized profession – the collecting and selling of rare coins, jewelry and watches. He’s now a real estate agent with Coldwell Banker in Austin. According to Justin, “the Centre for Neuro Skills has an amazing team that helped me literally get back on my feet and back to work. Caroline and I moved to Austin last year and absolutely love it. And now, we have our friends from CNS as neighbors. Austin is fortunate to have such an outstanding resource for brain injury rehabilitation.” Rehabilitative Technology Technology and advanced care systems at the Austin Clinic include: The ZeroG® Gait and Balance System, which helps patients relearn to walk, sit, stand, balance and improve gait. The Bioness Integrated Therapy System, which addresses vision, safety and motor balance training; the system supports returning to work and driving. The Independent Living Scale tracking system, which monitors patient progress. Tablets to record/integrate patient data in real time for analysis. Patient web portal for 24/7 secure access. Dedicated physician space, including a medical exam room, secured medication room and a nursing suite. Dedicated area for behavior analysis, including a meditation/quiet room. Patient and staff kitchen; computer center and offices for case management and administration. COVID-19 Safety Staff, patients and visitors are required to wear a mask at all times when in the clinic and common areas of residential homes. Clinic and residential visitors will have their temperatures taken upon entry. CNS clinics, homes and facilities observe CDC guidelines. About Centre for Neuro Skills Centre for Neuro Skills is an experienced and respected world leader in providing intensive rehabilitation and medical programs for those recovering from all types of brain injury. CNS covers a full spectrum of advanced care from residential and assisted living to outpatient/day treatment. Founded by Dr. Mark Ashley in 1980, CNS has seven locations in California and Texas. For more information about Center for Neuro Skills, visit: https://www.neuroskills.com/, Facebook, Twitter, LinkedIn, YouTube. For a video overview of CNS, visit: https://youtu.be/Jwqve9gWtEw Media, please note: Visual assets, including photos, are available. To request an interview with CNS leadership, clinical staff or patient guests at or before the Grand Opening, please contact Robin Carr at (415) 971-3991 or CNS@landispr.com. Contact Details Landis Communications Inc. Robin Carr +1 415-971-3991 CNS@landispr.com Company Website https://www.neuroskills.com/

June 10, 2021 10:42 AM Pacific Daylight Time

Image

Nearly 600 nominations submitted for Vietnam's first-ever global sci-tech prize

Vingroup

HANOI, VIETNAM - Media OutReach - 10 June 2021 - Vietnam's VinFuture Foundation announces that it has officially closed the nomination portal for the 2021 VinFuture Prize, recording nearly 600 nominations from more than 60 countries across six continents. The result has exceeded expectations, particularly for a newly established sci-tech prize opened for nominations less than four months ago, affirming the global scientific community's favorable response to VinFuture's mission of serving humanity. With a vision "to create meaningful change in the everyday lives of millions of people by promoting breakthrough scientific research and technological innovations", the VinFuture Foundation and the VinFuture Prize have drawn great enthusiasm from the global scientific and technological community. Notably, VinFuture has attracted prominent scientists and the world's leading research and academic institutions as well as innovators from developing countries. Nearly 100 nominated projects belong to the world's top 2% most-cited scientists, many of whom are laureates of prestigious awards such as the Nobel Prize, the Breakthrough Prize, the Tang Prize, the Japan Prize, among others. While the majority of candidates are from North America (31.6%), Asia (33.9%), and Europe (21%), VinFuture has received significant nominations from scientists in Oceania, Latin America, and Africa. In particular, female scientists were nominated in all four prize categories, accounting for 34.3% of the total nominees. All share the same aspiration of doing science for humanity, offering highly applicable and practical solutions to improve the quality of people's lives. These positive results are attributed to the strong support of prominent individuals and organizations, world-renowned scientists, as well as distinguished professors and experts from the Prize Council and Pre-screening Committee who have endorsed the VinFuture Prize among the global scientific community. Therefore, just four months after the initial call for nominations, the Prize has attracted nearly 1,200 nominators from the world's most reputable academic circles. These include Harvard University, where many prominent scientists converge; the University of Cambridge and the University of Oxford, home to many Nobel laureates and well-known for its natural sciences and engineering programs; the University of Tokyo, Japan's leading higher education organization; and other recognized organizations such as the National Institutes of Health (NIH) - the leading U.S. government agency in public health, the Max Planck Society - the world's leading research organization in science and technology, and the Chinese Academy of Science, one of the world's largest research organizations, to name but a few. "We are very pleased to see that the VinFuture Prize, while being the first of its kind from Vietnam, has been received so warmly by the global scientific community. Particularly, many prominent scientists have been nominated for the Prize. They have made truly meaningful contributions to the future of humanity by tackling global challenges from infectious diseases, environmental pollution, climate change to shortage of natural resources. The nominations for female scientists, scientists from developing countries, as well as pioneers in emerging fields are also very impressive," said Professor Thuc-Quyen Nguyen, University of California, Santa Barbara, Co-Chair of the VinFuture Prize Pre-Screening Committee. In addition to the impressive number of nominations and the prestige of nominated scientists and researchers, the VinFuture Prize has also seen an impressive diversity and depth of areas that address humanity's common challenges after its inaugural call for nominations. A significant number of nominated innovations focus on the prevention and treatment of infectious diseases on a global scale, sustainable poverty elimination, smart agriculture, clean food supply, renewable energy, and applications of artificial intelligence and digital technologies in education and life. Going forward, nominations will be reviewed by a twelve-member Pre-Screening Committee – prominent scientists and experts from various disciplines and countries – who will present the shortlisted candidates to the Prize Council in August 2021. Laureates will then be selected independently by the Prize Council comprising eleven distinguished individuals in academia, research, and industry with significant achievements and contributions to advancing human progress. The VinFuture Grand Prize will be awarded to innovators whose work has been proven to create the largest impact on humanity. It is also one of the world's largest prizes for science and technology to date, valued at US$ 3 million (equivalent to 70 billion Vietnamese Dong). Additionally, three special prizes will be awarded to innovators from developing countries, female innovators, and innovators with outstanding achievements in emerging fields, each worth US$500,000 (equivalent to 11.5 billion Vietnamese Dong). The laureates of the 2021 VinFuture Prize will be announced on December 20 th, 2021 and the official award ceremony will be held in Vietnam on January 20 th, 2022. About the VinFuture Prize The VinFuture Prize is a global science and technology prize founded by Mr. Pham Nhat Vuong, Chairman of Vingroup, and his wife, Madam Pham Thu Huong, to recognize groundbreaking scientific discoveries and technological inventions proven to create, or having the potential to create, better changes in the everyday lives of millions of people and foster a sustainable living environment for future generations.To learn more, please visit: https://vinfutureprize.org/ Contact Details Vingroup Media Contact v.nammh@vingroup.net

June 10, 2021 08:00 AM Eastern Daylight Time

Image

NextFerm Technologies Announces Successful Pilot for Industrial-Scale Production of ProteVin™, its Proprietary Vegan Protein

NextFerm Technologies Ltd.

NextFerm Technologies (TASE:NXFR), a Food-tech company developing ProteVin™, a vegan, non-GMO, yeast-based protein alternative, announced that it has successfully completed an industrial production pilot for ProteVin™. The successful pilot is the first of three milestones towards commercial production and launch of ProteVin™, planned in 2022. The two additional milestones are first, generating initial demand from the market and engagement with a first customer by the end of 2021; and second, entering into a production agreement with a subcontractor. As part of the pilot, which was conducted at production facilities in the US, the industrial production of the protein was examined while preserving the same characteristics that were achieved in the laboratory scale. Analysis of the results by independent laboratories, an internal team taste testers and a potential customer, showed that ProteVin™ successfully achieved all the pilot's objectives. Boaz Noy, Chief Executive Officer of NextFerm, said, “The successful industrial pilot of ProteVin™, marks an important achievement that brings us significantly closer to the planned commercial production and launch of ProteVin™ in 2022. The fast-growing alternative protein market is estimated at $13 billion, with an annual growth rate of 10%. The strong need for innovation by leading players in the food industry is for the protein itself, the raw material that is the foundation for all animal-derived food alternatives. The successful pilot reflects the outstanding value proposition of ProteVin™ as an alternative to animal-derived protein, with neutral flavor, the most important parameter for food manufacturers. This makes it accessible to a wide array of products such as milk and dairy substitutes, meat substitutes and additional categories such as infant nutrition, adult nutrition, and sports nutrition. Furthermore, for the first time, we bring the market a vegan protein with nutritional value that is higher than other plant-based proteins and that is comparable to animal-derived proteins. The nutritional advantage of ProteVin™ over other sources of plant-based proteins can be seen in its amino acid profile, which provides more essential amino acids (EAA) and more branched-chain amino acids (BCAA) and has better digestibility.” Mr. Noy Concluded, “We have recently begun sending commercial samples of ProteVin™ to potential customers worldwide. On the production side, we are in discussions with several potential subcontractors, in order to launch the product in 2022, as planned, and look forward to update our investors on our progress.” 1 st Target - Meeting the parameters determined that define the product: In tests performed by an independent laboratory, ProteVin™ met all parameters defined, including concentration of the protein, composition of amino acids, digestibility, light color, a product free of contaminants and allergens, and its compliance with food regulations and other quality parameters. 2 nd Target - Compliance with taste, flavor and odor requirements: ProteVin™ achieved neutral taste, flavor and odor requirements, without typical aftertaste and odor of various types of plant-based proteins. 3 rd Target - ability to supply samples of ProteVin™ for customers' approval: As part of the pilot, NextFerm produced a quantity of the protein sufficient to supply samples in the amount required for approval by potential customers. Customer testing includes integrating the protein in the prototype of their products, which is an essential step towards a commercial agreement with a customer. To the best of the company's knowledge, other than ProteVin™, there is currently no other protein alternative on the market with the same nutritional value and amino acid composition as animal-derived protein, and which has a neutral taste and flavor, with no aftertaste. In terms of regulation, ProteVin™ can be marketed in the US, Europe and other countries. About NextFerm Technologies NextFerm Technologies, traded on the Tel Aviv Stock Exchange (TASE:NXFR) is a food-tech company engaged in the research, development, manufacturing and marketing of innovative, functional and vegan yeast-derived, non-GMO protein alternatives for various applications in the food and food supplement markets and the growing market for animal-derived protein alternatives. NextFerm's flagship product is ProteVin™, a vegan yeast-derived protein alternative with nutritional value that is similar to animal-derived protein and a neutral flavor with no aftertastes that are typical of plant-based protein. ProteVin™ is designed for a variety of categories in the alternative protein market, which is estimated at $13 billion, with an annual growth rate of 10%, including the alternative meat market, milk alternatives and powder formulas for the infant nutrition market, for the wellbeing market and the market for athletes. NextFerm is gearing up for commercialization of the product in the US in 2022. Another product currently being sold is Astaferm®, an innovative astaxanthin-based antioxidant derived from yeast that has been sold in the US since the end of 2020 through well-established and leading brands in the food supplement market in the US. The company has additional products which have been licensed to Lallemand, a global giant focused on yeast. For more information, visit the NextFerm website at: www.nextferm.com Legal Notice Regarding Forward-Looking Statements This announcement also includes forecasts, projections, assessments, estimates and other information which refer to future events and matters, the realization of which is uncertain and not exclusively under the Company’s control (forward-looking information). The main facts and data used to support this information are facts and data regarding the current position of the Company and its businesses (including the scope of sales and levels of profitability, manpower, commercial engagements and more), facts and data regarding the current global position of the Company’s operating segments (including industry-specific financial developments, environmental regulatory developments, the competitive environment, technological developments, the reinsurance market and more), and macro-economic facts and data (including the economic situation both in Israel and around the world, yields in the capital markets, social and state developments and more), all as known by the Company when publishing this announcement. The forward-looking information included above in this announcement is significantly based upon, in addition to the existing information held by the Company, on the Company’s current assessments and expectations of future developments vis-a-vis each one of the aforementioned parameters, and the interconnectedness of each one of these developments. The Company has no certainty that its forecasts and assessments will indeed eventuate, and the Company’s operating results may be materially different than the results assessed or implicit based on that set forth above, inter alia, as a result of a change in any of the aforementioned factors. Contact Details NextFerm Technologies Ltd. Yossi Ohana - Chief Financial Officer +972 54-771-5893 yossio@nextferm.com Investor and Media Contact Meirav Gomeh-Bauer +972544764979 meirav@bauerg.com Company Website https://www.nextferm.com/

June 08, 2021 11:30 AM Eastern Daylight Time

UPDATING HEADLINE: AS U.S. FATAL OVERDOSES HIT A NATIONAL HIGH DURING PANDEMIC, SHATTERPROOF EXPANDS FREE TOOL TO MORE STATES TO HELP PEOPLE FIND TRUSTED AND HIGH-QUALITY ADDICTION TREATMENT

Shatterproof

Fatal drug overdoses have reached an all-time high in the U.S., with over 88,000 deaths occurring in the 12 months ending in October 2020 according to recent Centers for Disease Control and Prevention (CDC) data. To help those in need, Shatterproof, a nonprofit organization dedicated to reversing the addiction crisis in the United States, is expanding and enhancing its free tool, ATLAS ®, to connect individuals with high-quality, appropriate addiction treatment. ATLAS is currently available in Delaware, Louisiana, Massachusetts, New York, North Carolina, and West Virginia. Shatterproof is excited to announce today that ATLAS is also expanding its reach to Florida, New Jersey, Oklahoma, and Pennsylvania. “It is now more critical than ever, given the profound uptick in fatal overdoses and the impact that COVID-19 has had on addiction and mental health, that people are able to access a trusted, free resource when searching for quality substance use disorder treatment for themselves or a loved one,” says Jen Velez, Chief Impact Officer, Shatterproof. “Trust is everything. We know that it can be a confusing, scary time when someone is seeking help, and we want to ensure that the information available to find quality care is trusted, unbiased, and meets the person’s needs.” ATLAS identifies addiction treatment providers’ use of evidence-based best practices, and publicly displays this information to support those in need and their loved ones in navigating to appropriate, quality care. Individuals can search for and compare treatment options using criteria that are important to them – such as location, particular services offered, and insurance accepted. ATLAS also allows patients (or their family members acting as a proxy) to provide feedback on their treatment experience. The platform lists all authorized treatment providers in a state. The current ATLAS platform has many unique features: Facilities’ use of best practices measured against Shatterproof National Principles of Care, which are evidence-based standards derived from the landmark 2016 Surgeon General’s Report on Addiction as well as subject matter and other clinical experts; Display of feedback from patients and family members, updated daily; An Addiction Treatment Needs Assessment, created in collaboration with the subject matter expertise of the American Society of Addiction Medicine (ASAM) and OpenBeds, to help guide the search based on an individual’s needs and severity; Ability to search and filter using criteria such as location, services offered, and insurance provider. The ATLAS platform, www.TreatmentATLAS.org has seen more than 100,000 sessions since launch in July 2020 and will be updated over the coming months to enhance the experience of those seeking treatment. ATLAS 2021 enhancements include: Availability of all content in Spanish language Improved display of insurance information Integration of state resources into ATLAS Ability to search for facilities by name Updated educational content to increase readability. In addition, the platform also offers secure access to critical data for state policymakers, providers, and insurance payers to further drive improvements to the addiction treatment space, fueled by increased accountability and transparency: Addiction treatment providers can compare their quality data to that of their peers and use these metrics to inform internal quality improvement efforts. Metrics allow payers to assess the performance of providers to more easily align financial incentives to support quality care over quantity. State policymakers can use the data to better direct policy, access changes, and disseminate resources such as technical assistance to support providers. When the platform launches in Florida, New Jersey, Oklahoma, and Pennsylvania, it will feature all of these components, using facility-level data collected in each state. In the interim, the ATLAS team will be working with stakeholders and partners in each of the ten states to collect data from addiction treatment providers, analyze and validate these data using industry best practices, and disseminate technical assistance resources to providers. Shatterproof partnered with key thought leaders and subject matter experts in the addiction treatment space to create ATLAS. The platform is based on quality measurement system best practices and uses metrics developed via a multi-step process, culminating with a National Quality Forum (NQF) expert panel and public comment period. Shatterproof continues to revise and update the ATLAS measures displayed on the platform to ensure they reflect current evidence in the field. ATLAS is funded by Arnold Ventures; the Longwood Foundation; state partners: the Louisiana Department of Health, the Massachusetts Bureau of Substance Addiction Services, the New York State Office of Addiction Services and Supports, the Oklahoma Department of Mental Health and Substance Abuse Services, the Pennsylvania Department of Drug and Alcohol Programs, and the West Virginia Department of Health & Human Resources – Office of Drug Control Policy, and several national and state-based health care companies: Aetna, a CVS Health Company, Blue Cross and Blue Shield of North Carolina, Cigna, GuideWell in partnership with New Directions Behavioral Health, Horizon Blue Cross Blue Shield of New Jersey, and UnitedHealth Group. About Shatterproof: Shatterproof is a national nonprofit organization dedicated to reversing the addiction crisis in the United States. Shatterproof harnesses the models of business, the rigor of science and the power of a national movement to create change and save lives through three pillars of work: revolutionizing the addiction treatment system, breaking down addiction-related stigmas and supporting and empowering our communities. To learn more visit www.Shatterproof.org. Contact Details Shatterproof Holly Jespersen +1 646-334-1024 hjespersen@shatterproof.org Company Website https://www.shatterproof.org/

June 08, 2021 10:02 AM Eastern Daylight Time

1 ... 271 272 273 274 275 ... 307